Ilaris® in Urticarial Vasculitis – Investigation of Treatment Responses
Condition(s):Urticaria; VasculitisLast Updated:May 31, 2012Completed
Hide Studies Not Open or Pending
Condition(s):Urticaria; VasculitisLast Updated:May 31, 2012Completed
Condition(s):ANCA Associated Vasculitis; Maintenance TherapyLast Updated:November 30, 2021Recruiting
Condition(s):Vasculitis; Anti-Neutrophil Cytoplasmic AntibodyLast Updated:June 8, 2010Completed
Condition(s):ANCA-associated Primary Necrotizing VasculitidesLast Updated:October 13, 2022Completed
Condition(s):ANCA Associated VasculitisLast Updated:April 7, 2022Recruiting
Condition(s):VasculitisLast Updated:April 17, 2018Completed
Condition(s):Lupus Nephritis; ANCA Associated VasculitisLast Updated:February 26, 2024Recruiting
Condition(s):Infection; VasculitisLast Updated:October 22, 2021Completed
Condition(s):Systemic Lupus Erythematosus; ANCA Associated VasculitisLast Updated:February 17, 2006Completed
Condition(s):Immunological Testing in Small-vessel VasculitisLast Updated:January 22, 2021Unknown status
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.